vs

Side-by-side financial comparison of OneMain Holdings, Inc. (OMF) and ResMed (RMD). Click either name above to swap in a different company.

ResMed is the larger business by last-quarter revenue ($1.4B vs $1.1B, roughly 1.3× OneMain Holdings, Inc.). ResMed runs the higher net margin — 27.6% vs 18.7%, a 8.9% gap on every dollar of revenue. On growth, ResMed posted the faster year-over-year revenue change (11.0% vs 8.3%). Over the past eight quarters, OneMain Holdings, Inc.'s revenue compounded faster (10.4% CAGR vs 7.8%).

OneMain Holdings, Inc. is an American financial services holding company headquartered in Evansville, Indiana, with central offices throughout the United States. The company wholly owns OneMain Finance Corporation and its subsidiaries, through which it operates in the consumer finance and insurance industries as OneMain Financial. Its business primarily focuses on providing personal loans and optional insurance products to customers with limited access to traditional lenders, such as banks an...

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

OMF vs RMD — Head-to-Head

Bigger by revenue
RMD
RMD
1.3× larger
RMD
$1.4B
$1.1B
OMF
Growing faster (revenue YoY)
RMD
RMD
+2.6% gap
RMD
11.0%
8.3%
OMF
Higher net margin
RMD
RMD
8.9% more per $
RMD
27.6%
18.7%
OMF
Faster 2-yr revenue CAGR
OMF
OMF
Annualised
OMF
10.4%
7.8%
RMD

Income Statement — Q4 FY2025 vs Q4 FY2026

Metric
OMF
OMF
RMD
RMD
Revenue
$1.1B
$1.4B
Net Profit
$204.0M
$392.6M
Gross Margin
61.8%
Operating Margin
22.8%
34.6%
Net Margin
18.7%
27.6%
Revenue YoY
8.3%
11.0%
Net Profit YoY
61.9%
13.9%
EPS (diluted)
$1.71
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OMF
OMF
RMD
RMD
Q2 26
$1.4B
Q1 26
$1.4B
Q4 25
$1.1B
$1.4B
Q3 25
$1.1B
$1.3B
Q2 25
$1.0B
$1.3B
Q1 25
$996.0M
$1.3B
Q4 24
$1.0B
$1.3B
Q3 24
$981.0M
$1.2B
Net Profit
OMF
OMF
RMD
RMD
Q2 26
$392.6M
Q1 26
$398.7M
Q4 25
$204.0M
$392.6M
Q3 25
$199.0M
$348.5M
Q2 25
$167.0M
$379.7M
Q1 25
$213.0M
$365.0M
Q4 24
$126.0M
$344.6M
Q3 24
$157.0M
$311.4M
Gross Margin
OMF
OMF
RMD
RMD
Q2 26
61.8%
Q1 26
62.2%
Q4 25
61.8%
Q3 25
61.5%
Q2 25
60.8%
Q1 25
59.3%
Q4 24
58.6%
Q3 24
58.6%
Operating Margin
OMF
OMF
RMD
RMD
Q2 26
34.6%
Q1 26
34.9%
Q4 25
22.8%
34.6%
Q3 25
24.5%
33.4%
Q2 25
20.9%
33.7%
Q1 25
27.6%
33.0%
Q4 24
16.3%
32.5%
Q3 24
21.1%
31.6%
Net Margin
OMF
OMF
RMD
RMD
Q2 26
27.6%
Q1 26
27.9%
Q4 25
18.7%
27.6%
Q3 25
18.6%
26.1%
Q2 25
16.3%
28.2%
Q1 25
21.4%
28.3%
Q4 24
12.5%
26.9%
Q3 24
16.0%
25.4%
EPS (diluted)
OMF
OMF
RMD
RMD
Q2 26
$2.68
Q1 26
$2.74
Q4 25
$1.71
$2.68
Q3 25
$1.67
$2.37
Q2 25
$1.40
$2.58
Q1 25
$1.78
$2.48
Q4 24
$1.05
$2.34
Q3 24
$1.31
$2.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OMF
OMF
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$914.0M
$1.4B
Total DebtLower is stronger
$22.7B
$663.8M
Stockholders' EquityBook value
$3.4B
$6.3B
Total Assets
$27.4B
$8.5B
Debt / EquityLower = less leverage
6.67×
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OMF
OMF
RMD
RMD
Q2 26
$1.4B
Q1 26
$1.7B
Q4 25
$914.0M
$1.4B
Q3 25
$658.0M
$1.4B
Q2 25
$769.0M
$1.2B
Q1 25
$627.0M
$932.7M
Q4 24
$458.0M
$521.9M
Q3 24
$577.0M
$426.4M
Total Debt
OMF
OMF
RMD
RMD
Q2 26
$663.8M
Q1 26
$664.1M
Q4 25
$22.7B
$403.9M
Q3 25
$22.3B
$408.7M
Q2 25
$22.1B
$658.4M
Q1 25
$21.5B
$663.1M
Q4 24
$21.4B
$662.9M
Q3 24
$21.1B
$667.6M
Stockholders' Equity
OMF
OMF
RMD
RMD
Q2 26
$6.3B
Q1 26
$6.5B
Q4 25
$3.4B
$6.3B
Q3 25
$3.4B
$6.1B
Q2 25
$3.3B
$6.0B
Q1 25
$3.3B
$5.5B
Q4 24
$3.2B
$5.3B
Q3 24
$3.2B
$5.2B
Total Assets
OMF
OMF
RMD
RMD
Q2 26
$8.5B
Q1 26
$8.8B
Q4 25
$27.4B
$8.5B
Q3 25
$27.0B
$8.3B
Q2 25
$26.6B
$8.2B
Q1 25
$26.0B
$7.6B
Q4 24
$25.9B
$7.1B
Q3 24
$25.6B
$7.2B
Debt / Equity
OMF
OMF
RMD
RMD
Q2 26
0.11×
Q1 26
0.10×
Q4 25
6.67×
0.06×
Q3 25
6.61×
0.07×
Q2 25
6.63×
0.11×
Q1 25
6.55×
0.12×
Q4 24
6.72×
0.13×
Q3 24
6.59×
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OMF
OMF
RMD
RMD
Operating Cash FlowLast quarter
$865.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
4.24×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OMF
OMF
RMD
RMD
Q2 26
Q1 26
Q4 25
$865.0M
$339.7M
Q3 25
$828.0M
$457.3M
Q2 25
$774.0M
$538.8M
Q1 25
$665.0M
$578.7M
Q4 24
$752.0M
$308.6M
Q3 24
$677.0M
$325.5M
Free Cash Flow
OMF
OMF
RMD
RMD
Q2 26
Q1 26
Q4 25
$311.2M
Q3 25
$414.4M
Q2 25
$508.2M
Q1 25
$557.9M
Q4 24
$288.0M
Q3 24
$307.7M
FCF Margin
OMF
OMF
RMD
RMD
Q2 26
Q1 26
Q4 25
21.9%
Q3 25
31.0%
Q2 25
37.7%
Q1 25
43.2%
Q4 24
22.5%
Q3 24
25.1%
Capex Intensity
OMF
OMF
RMD
RMD
Q2 26
Q1 26
Q4 25
2.0%
Q3 25
3.2%
Q2 25
2.3%
Q1 25
1.6%
Q4 24
1.6%
Q3 24
1.5%
Cash Conversion
OMF
OMF
RMD
RMD
Q2 26
Q1 26
Q4 25
4.24×
0.87×
Q3 25
4.16×
1.31×
Q2 25
4.63×
1.42×
Q1 25
3.12×
1.59×
Q4 24
5.97×
0.90×
Q3 24
4.31×
1.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons